OSNovative Systems Inc. receives 2014 North American Frost & Sullivan's Award for New Product Innovation Leadership
Santa Clara, CA - - June 16 2014 - OSNovative Systems Inc., a leader in shattering the stereotypes associated with modern wound care delivery, is pleased to announce that it has been awarded the Frost & Sullivan 2014 North American Award for New Product Innovation Leadership.
A startup company based in Silicon Valley has developed Enluxtra, the only wound care dressing in its class that is suitable for use on all types of wounds at any stage of healing. Enluxtra exclusively represents a fundamentally new category of dynamic, multifunctional, self-adaptive wound care products.
Each year, Frost & Sullivan presents the New Product Innovation Leadership Award to the company that has developed an innovative element in a product by leveraging leading-edge technologies. The companies commended as New Product Innovation Award recipients are those committed to groundbreaking innovation and successful in translating brilliant ideas into long-term growth.
For a company to be honored with the award, the new product's performance must score the highest both in creativity and implementation based on specific key benchmarking criteria. The award recognizes the value-added features and increased ROI of the product, which, in turn, increases market penetration potential.
The composition and functionality of Enluxtra's material make it a true technological wonder. While in direct contact with the wound, the dressing material is capable of sensing and analyzing the wound condition. It then automatically and reversibly adjusts its function to accommodate the wound’s needs, which may frequently and unpredictably change. Unlike other, single-function, wound dressings, Enluxtra ensures that the current condition of each part of the wound is addressed simultaneously, providing an optimal moist healing environment regardless of the nature of that condition.
The dressing’s ability to automatically adjust its function depending on the wound's needs allows clinicians to keep the dressing on the wound significantly longer, resulting in fewer disruptions of wound homeostasis, which is a known critical condition for fast wound healing. The dressing can address factors that impede healing including excess of fluid, overdrying, bacterial exposure, temperature shock and other issues that can arise from frequent dressing changes. Additionally, the self-adaptive wound dressing encourages the body’s natural healing, reducing the need for surgical removal of dead tissue (sharp debridement).
Enluxtra’s adaptability to moisture levels makes the dressing an ideal choice for virtually any wound type. Higher absorption and structural integrity distinguish it from competing products. Further, Enluxtra overcomes the constraints associated with utilizing multiple products in the right order at the appropriate phase of healing, removing the guesswork from wound management.
Patients prefer Enluxtra for its drug-free pain reduction capabilities, excellent odor management, and reduced frequency of dressing changes. More than 20,000 patients have been treated with Enluxtra in the United States, an endorsement of the technology’s superior qualities.
The introduction of this proprietary self-adaptive wound care technology opens a new direction in modern wound care delivery, bringing it to a more advanced level of clinical care while dramatically reducing treatment costs for care providers and patients.
In view of the deepening financial constraints of society, self-adaptive wound care technology may help to meet the fast growing demand for wound care, driven by an aging population and the spread of chronic diseases such as diabetes.
“The use of Enluxtra translates into significant cost-savings and successful treatment outcomes,” said Frost & Sullivan Research Analyst Geethu Roshan Verghese. “By addressing the needs of healthcare professionals and patients alike, Enluxtra has effectively bridged vital gaps in the wound care industry.”
About Frost & Sullivan
Frost & Sullivan, the Growth Partnership Company, works in collaboration with clients to leverage visionary innovation that addresses the global challenges and related growth opportunities that will make or break today's market participants. For more than 50 years, we have been developing growth strategies for the global 1000, emerging businesses, the public sector and the investment community. Is your organization prepared for the next profound wave of industry convergence, disruptive technologies, increasing competitive intensity, Mega Trends, breakthrough best practices, changing customer dynamics and emerging economies. To join Frost & Sullivan’s Growth Partnership, visit the website at www.frost.com.
About OSNovative Systems Inc.
OSNovative Systems, Inc. is a pioneer in self-adaptive wound care technology committed to developing, manufacturing and selling proprietary devices for advanced wound management, combat/emergency medicine and cosmetic skin care. This Silicon Valley-based startup company is owned and managed by a team of dedicated professionals, who are passionate about bringing the most innovative wound care products to healthcare providers and patients.
For more information about self-adaptive technology, testimonies and clinical studies please visit the website at www.AnyWound.com
Contact Information:
Polina D. Krasnova
Communications and PR Manager
OSNovative Systems, Inc.
Direct Line: 650-483-9938
Toll Free: 888-519-2297 ext. 417
Email: polinak@osnovative.com
Santa Clara, CA - - June 16 2014 - OSNovative Systems Inc., a leader in shattering the stereotypes associated with modern wound care delivery, is pleased to announce that it has been awarded the Frost & Sullivan 2014 North American Award for New Product Innovation Leadership.
A startup company based in Silicon Valley has developed Enluxtra, the only wound care dressing in its class that is suitable for use on all types of wounds at any stage of healing. Enluxtra exclusively represents a fundamentally new category of dynamic, multifunctional, self-adaptive wound care products.
Each year, Frost & Sullivan presents the New Product Innovation Leadership Award to the company that has developed an innovative element in a product by leveraging leading-edge technologies. The companies commended as New Product Innovation Award recipients are those committed to groundbreaking innovation and successful in translating brilliant ideas into long-term growth.
For a company to be honored with the award, the new product's performance must score the highest both in creativity and implementation based on specific key benchmarking criteria. The award recognizes the value-added features and increased ROI of the product, which, in turn, increases market penetration potential.
The composition and functionality of Enluxtra's material make it a true technological wonder. While in direct contact with the wound, the dressing material is capable of sensing and analyzing the wound condition. It then automatically and reversibly adjusts its function to accommodate the wound’s needs, which may frequently and unpredictably change. Unlike other, single-function, wound dressings, Enluxtra ensures that the current condition of each part of the wound is addressed simultaneously, providing an optimal moist healing environment regardless of the nature of that condition.
The dressing’s ability to automatically adjust its function depending on the wound's needs allows clinicians to keep the dressing on the wound significantly longer, resulting in fewer disruptions of wound homeostasis, which is a known critical condition for fast wound healing. The dressing can address factors that impede healing including excess of fluid, overdrying, bacterial exposure, temperature shock and other issues that can arise from frequent dressing changes. Additionally, the self-adaptive wound dressing encourages the body’s natural healing, reducing the need for surgical removal of dead tissue (sharp debridement).
Enluxtra’s adaptability to moisture levels makes the dressing an ideal choice for virtually any wound type. Higher absorption and structural integrity distinguish it from competing products. Further, Enluxtra overcomes the constraints associated with utilizing multiple products in the right order at the appropriate phase of healing, removing the guesswork from wound management.
Patients prefer Enluxtra for its drug-free pain reduction capabilities, excellent odor management, and reduced frequency of dressing changes. More than 20,000 patients have been treated with Enluxtra in the United States, an endorsement of the technology’s superior qualities.
The introduction of this proprietary self-adaptive wound care technology opens a new direction in modern wound care delivery, bringing it to a more advanced level of clinical care while dramatically reducing treatment costs for care providers and patients.
In view of the deepening financial constraints of society, self-adaptive wound care technology may help to meet the fast growing demand for wound care, driven by an aging population and the spread of chronic diseases such as diabetes.
“The use of Enluxtra translates into significant cost-savings and successful treatment outcomes,” said Frost & Sullivan Research Analyst Geethu Roshan Verghese. “By addressing the needs of healthcare professionals and patients alike, Enluxtra has effectively bridged vital gaps in the wound care industry.”
About Frost & Sullivan
Frost & Sullivan, the Growth Partnership Company, works in collaboration with clients to leverage visionary innovation that addresses the global challenges and related growth opportunities that will make or break today's market participants. For more than 50 years, we have been developing growth strategies for the global 1000, emerging businesses, the public sector and the investment community. Is your organization prepared for the next profound wave of industry convergence, disruptive technologies, increasing competitive intensity, Mega Trends, breakthrough best practices, changing customer dynamics and emerging economies. To join Frost & Sullivan’s Growth Partnership, visit the website at www.frost.com.
About OSNovative Systems Inc.
OSNovative Systems, Inc. is a pioneer in self-adaptive wound care technology committed to developing, manufacturing and selling proprietary devices for advanced wound management, combat/emergency medicine and cosmetic skin care. This Silicon Valley-based startup company is owned and managed by a team of dedicated professionals, who are passionate about bringing the most innovative wound care products to healthcare providers and patients.
For more information about self-adaptive technology, testimonies and clinical studies please visit the website at www.AnyWound.com
Contact Information:
Polina D. Krasnova
Communications and PR Manager
OSNovative Systems, Inc.
Direct Line: 650-483-9938
Toll Free: 888-519-2297 ext. 417
Email: polinak@osnovative.com